Publications

Filter publications:
Healthcare & Life Sciences
GSK

Rotavirus vaccine – Technical and economic arguments regarding implementation of rotavirus vaccination in the Danish immunisation programme

Healthcare & Life Sciences
US Hereditary Angioedema Association (HAEA)

Development and validation of a US quality of life instrument for hereditary angioedema due to C1 inhibitor deficiency

Healthcare & Life Sciences
PhRMA

Regulatory data protection for pharmaceuticals – How implementing RDP in China will benefit society, industry and the Chinese economy

Healthcare & Life Sciences
European Federation of Pharmaceutical Industries and Associations (EFPIA)

Cost and value of regulatory data protection

Healthcare & Life Sciences
EURORDIS, Alexion AstraZeneca Rare Disease, Takeda, Orphanet

Enabling, not rewarding: How to design a high unmet medical needs category to drive, not deter, innovation in orphan medicinal products

Healthcare & Life Sciences
Novartis Healthcare A/S

Real-world evidence on the economic implications of CGRP inhibitors as preventive treatment of migraine in Denmark

Healthcare & Life Sciences
OD Expert Group

European Union Health Technology Assessment Fit for Rare Diseases

Healthcare & Life Sciences
Novo Nordisk A/S

European trade in pharmaceutical goods

Healthcare & Life Sciences
Alliance for Safe Online Pharmacy in the EU (ASOP EU)

Unlocking the benefits of online access to prescription medicines across the EU

Healthcare & Life Sciences
Novo Nordisk

The economic impact of the pharmaceutical industry in Europe

Healthcare & Life Sciences
PhRMA

Regulatory data protection – How adopting regulatory data protection can increase medicine availability, innovation, and investment

Healthcare & Life Sciences
Economists Without Borders / Impactly

New tool assesses the impact of initiatives against loneliness

Healthcare & Life Sciences
Takeda

Development of novel therapies

Healthcare & Life Sciences
Takeda

Innovating for people living with a rare disease

Healthcare & Life Sciences
Gilead Sciences, Inc.

The impact of remdesivir in the European Union

Healthcare & Life Sciences
Interfarma and PhRMA

Regulatory data protection for pharmaceuticals